Literature DB >> 22573310

The molecular profile of microglia under the influence of glioma.

Wei Li1, Manuel B Graeber.   

Abstract

Microglia, which contribute substantially to the tumor mass of glioblastoma, have been shown to play an important role in glioma growth and invasion. While a large number of experimental studies on functional attributes of microglia in glioma provide evidence for their tumor-supporting roles, there also exist hints in support of their anti-tumor properties. Microglial activities during glioma progression seem multifaceted. They have been attributed to the receptors expressed on the microglia surface, to glioma-derived molecules that have an effect on microglia, and to the molecules released by microglia in response to their environment under glioma control, which can have autocrine effects. In this paper, the microglia and glioma literature is reviewed. We provide a synopsis of the molecular profile of microglia under the influence of glioma in order to help establish a rational basis for their potential therapeutic use. The ability of microglia precursors to cross the blood-brain barrier makes them an attractive target for the development of novel cell-based treatments of malignant glioma.

Entities:  

Mesh:

Year:  2012        PMID: 22573310      PMCID: PMC3408253          DOI: 10.1093/neuonc/nos116

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  285 in total

1.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

2.  CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).

Authors:  Janka Held-Feindt; Kirsten Hattermann; Susanne Sebens Müerköster; Hanna Wedderkopp; Friederike Knerlich-Lukoschus; Hendrik Ungefroren; H Maximilian Mehdorn; Rolf Mentlein
Journal:  Exp Cell Res       Date:  2010-02-23       Impact factor: 3.905

3.  Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans.

Authors:  T Moriyama; H Kataoka; H Kawano; K Yokogami; S Nakano; T Goya; H Uchino; M Koono; S Wakisaka
Journal:  Cancer Lett       Date:  1998-02-27       Impact factor: 8.679

4.  The alteration of prostaglandin E2 levels in patients with brain tumors before and after tumor removal.

Authors:  Joon-Khim Loh; Shiuh-Lin Hwang; Ann-Shung Lieu; Tzuu-Yuan Huang; Shen-Long Howng
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

5.  Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.

Authors:  Manuel Rodriguez; Lydia Alvarez-Erviti; Francisco J Blesa; Maria C Rodríguez-Oroz; Ainhoa Arina; Ignacio Melero; Luís Isaac Ramos; Jose A Obeso
Journal:  Neurobiol Dis       Date:  2007-08-07       Impact factor: 5.996

6.  Stat3 activation is required for the growth of U87 cell-derived tumours in mice.

Authors:  Atreyi Dasgupta; Baisakhi Raychaudhuri; Talat Haqqi; Richard Prayson; Erwin G Van Meir; Michael Vogelbaum; Saikh Jaharul Haque
Journal:  Eur J Cancer       Date:  2008-12-31       Impact factor: 9.162

7.  White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues.

Authors:  T Yamada; Y Yoshiyama; H Sato; M Seiki; A Shinagawa; M Takahashi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.

Authors:  Michael Platten; Alexandra Kretz; Ulrike Naumann; Steffen Aulwurm; Kensuke Egashira; Stefan Isenmann; Michael Weller
Journal:  Ann Neurol       Date:  2003-09       Impact factor: 10.422

9.  CXCR4 and SDF-1 production are stimulated by hepatocyte growth factor and promote glioma cell invasion.

Authors:  Hanjun Tu; Zhangming Zhou; Qingle Liang; Zhiqiang Li; Dongsheng Li; Jun Qing; Hui Wang; Li Zhang
Journal:  Onkologie       Date:  2009-05-19

10.  Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes.

Authors:  M C Kuppner; Y Sawamura; M F Hamou; N de Tribolet
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

View more
  159 in total

1.  Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.

Authors:  Krishna P L Bhat; Veerakumar Balasubramaniyan; Brian Vaillant; Ravesanker Ezhilarasan; Howard Colman; Erik P Sulman; Kenneth Aldape; Karlijn Hummelink; Faith Hollingsworth; Khalida Wani; Lindsey Heathcock; Johanna D James; Lindsey D Goodman; Siobhan Conroy; Lihong Long; Nina Lelic; Suzhen Wang; Joy Gumin; Divya Raj; Yoshinori Kodama; Aditya Raghunathan; Adriana Olar; Kaushal Joshi; Christopher E Pelloski; Amy Heimberger; Se Hoon Kim; Daniel P Cahill; Ganesh Rao; Wilfred F A Den Dunnen; Hendrikus W G M Boddeke; Heidi S Phillips; Ichiro Nakano; Frederick F Lang
Journal:  Cancer Cell       Date:  2013-08-29       Impact factor: 31.743

Review 2.  Glioblastoma niches: from the concept to the phenotypical reality.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Ilaria Bisogno; Cristina Casalone; Laura Annovazzi
Journal:  Neurol Sci       Date:  2018-05-08       Impact factor: 3.307

Review 3.  Prostaglandin E2 Signaling: Alternative Target for Glioblastoma?

Authors:  Jianxiong Jiang; Jiange Qiu; Qianqian Li; Zhi Shi
Journal:  Trends Cancer       Date:  2017-01-11

Review 4.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

5.  Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model.

Authors:  Anjali Sharma; Joshua E Porterfield; Elizabeth Smith; Rishi Sharma; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2018-06-05       Impact factor: 9.776

6.  Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor Growth.

Authors:  Tarun Saxena; Johnathan G Lyon; S Balakrishna Pai; Daniel Pare; Jessica Amero; Lohitash Karumbaiah; Sheridan L Carroll; Eric Gaupp; Ravi V Bellamkonda
Journal:  Adv Healthc Mater       Date:  2018-12-11       Impact factor: 9.933

7.  Glioma and microglia, a double entendre.

Authors:  Korneel Grauwet; E Antonio Chiocca
Journal:  Nat Immunol       Date:  2016-10-19       Impact factor: 25.606

8.  Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.

Authors:  Theresa Barberi; Allison Martin; Rahul Suresh; David J Barakat; Sarah Harris-Bookman; Charles G Drake; Michael Lim; Alan D Friedman
Journal:  Cancer Immunol Immunother       Date:  2018-07-21       Impact factor: 6.968

Review 9.  Glutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environment.

Authors:  Susan C Buckingham; Stefanie Robel
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

Review 10.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.